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Background and aims: Carotid artery intima-media thickness (CIMT) may be used as a biomarker for early
cognitive impairment. However, the results of the association between CIMT and cognitive function in
middle-aged subjects are mixed. We aimed to investigate this association in a large Brazilian sample with
no history of stroke at baseline. Additionally, we tested the effect of interactions between CIMT and
cardiovascular risk factors on cognitive performance.
Methods: In this cross-sectional study, cognition was evaluated using the delayed word recall (DWRT),
the category ﬂuency, and the trail making tests (TMT). CIMT was measured at the common carotid artery.
The association between CIMT and cognitive tests was investigated using linear regression models,
adjusted for an extensive set of possible confounding variables. We also included interaction terms with
selected risk factors.
Results: The mean age of the 8208 participants was 49.6 ± 7.3 years, 44% were male, and 56% White.
Increase in CIMT was associated with worse performance on the DWRT (b ¼ 0.433, 95%
CI ¼ 0.724;0.142, p ¼ 0.004). We found effect modiﬁcation of the association between cognitive
function and CMIT by self-reported heart failure and alcohol intake. Participants had worse performance
in the TMT if they had greater CIMT and current alcohol use (p < 0.0001). The interaction between CIMT
and heart failure on TMT performance was not signiﬁcant after adjustment for multiple comparisons
(p ¼ 0.07).
Conclusions: In this sample of middle-aged adults, CIMT was inversely associated with memory function.
Additionally, the presence of alcohol use resulted in a stronger association of CIMT with worse perfor-
mance on an executive function test.
© 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
In 2010, 36 million people worldwide had dementia and that
number is expected to reach 115 million in 2050 [1]. In 2013, 5.2, 3º andar S~ao Paulo, SP,
.
rved.million Americans were suffering from Alzheimer's disease (AD),
leading to estimated related health care costs of $203 billion [2].
Dementia is the only disease among the top 10 causes of death in
the U.S. that has no effective treatment or prevention. One expla-
nation for this fact is that previous interventions were tested in
patients that already had advanced neuropathological disease.
Dementia has a long pre-clinical phase, with evidence of neuro-
pathological lesions starting 20 years before the onset of clinically
C.K. Suemoto et al. / Atherosclerosis 243 (2015) 510e515 511relevant symptoms [3]. Therefore, identifying individuals at higher
risk of dementia at early stages of the disease is essential to guide
effective therapeutic and preventive strategies.
Atherosclerosis has been associatedwith higher risk of cognitive
decline [4e6], and control of cardiovascular risk factors (CVRF) may
be an effective way to prevent it [7]. Carotid artery intima-media
thickness (CIMT), a non-invasive and accessible measure of sub-
clinical atherosclerosis, can be used to identify individuals at higher
risk of cognitive impairment. However, controversy remains about
the utility of CIMT to predict cognitive impairment. CIMT has been
associatedwith higher risk of cognitive decline andworse cognitive
function in some studies [6,8e10], but not in others [11e14]. In
addition, studies should focus on middle-aged adults without his-
tory of stroke to identify individuals at early stages of cognitive
impairment; however, few studies had included participants
younger than 55 years old [9,15]. Likewise, it is important to
investigate the interaction of CIMT and CVRFs to identify special
groups of individuals at higher risk of cognitive decline. Finally,
studies about the association between CIMT and cognitive impair-
ment have been conducted in the US, Europe, and China, with no
evidence from other countries. Therefore, we aim to investigate the
association between CIMT and cognitive function in a large Bra-
zilian sample of middle age adults (mean age of 49.6 years) without
history of stroke. We also aim to test the presence of interactions
between CIMT and CVRFs on the performance of cognitive tests.
2. Methods
2.1. Participants
The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) is
a cohort study of 15,105 civil servants, 35 years and older, from six
cities in Brazil (S~ao Paulo, Belo Horizonte, Porto Alegre, Salvador,
Rio de Janeiro, and Vitoria). Active and retired employees of six
institutions were enrolled from August 2008 to December 2010.
Baseline assessment included information on sociodemographics,
clinical history, occupational exposure, family history of diseases,
access to health care, lifestyle factors, and mental health. Anthro-
pometric and laboratory measurements were also performed. The
study was approved by the local institutional review boards, and all
individuals signed informed consent at the time of enrollment. A
detailed description the ELSA-Brasil study can be found elsewhere
[16,17].
For this analysis, we excluded participants that were 65 years
and older to represent a sample of middle-aged participants.
Moreover, we excluded participants with a clinical history of stroke
at baseline, and participants that were using medications (neuro-
leptics, antiparkinsonian agents, and anticonvulsants) that indicate
the presence of active neurologic or psychiatric diseases, or could
directly interfere with performance on cognitive tests. We also
excluded participants with a C-reactive protein (CRP) > 10 mg/dL
due to the possible presence of acute clinical events, which could
potentially impact the cognitive function evaluation. Finally, we
excluded participants with incomplete data for cognitive tests,
CIMT measures, or possible confounding variables.
2.2. Assessment of cognitive function
We used 3 neuropsychological tests to evaluate cognitive func-
tion: the CERAD delayed word recall test (DWRT) [18], the category
ﬂuency test (CFT) [19], and the Trail Making Test version B (TMT)
[20]. The choice of tests was based on: (1) evaluation of multiple
cognitive domains (e.g. verbal learning, memory, language, execu-
tive function, attention, and speed of processing); (2) widely used
tests by the research community; (3) adaptation and validation toBrazilian Portuguese; (4) the ability of these tests to detect cogni-
tive impairment [21e23]; and (5) easiness and duration of appli-
cation [24]. Test protocols were standardized and trained
examiners administered the tests in a ﬁxed order during one ses-
sion in a quiet room, with good lighting and low levels of noise or
other distracting stimulations. All cognitive evaluations were
recorded to audio ﬁles and a supervisor reviewed them once a
week.
The DWRT is a test of verbal learning and recent memory. We
used the Brazilian version of the Consortium to Establish a Registry
for Alzheimer's disease (CERAD) ten word list [25]. Participants
were asked to read and learn 10 words after 3 exposures to each
word. After a 5-min ﬁlled delay, participants had 60 s to record the
words. The score was equal to the number of recalled words. The
CFT is a test of language and executive function. Participants were
asked to generate as many categories of animals as possible. The
score was equal to the total number of generated words. The TMT is
a test of executive function, speed of processing, and attention.
Participants were instructed to draw lines connecting letters and
numbers in an order that alternated between increasing numeric
value and alphabetic order. The test score was the total time (in
seconds) taken to complete the task.
2.3. Carotid intima media thickness measurement
The same protocol for the CIMT measurement was applied in all
study centers using a Toshiba ultrasound machine (Aplio XG™)
with a 7.5 MHz linear transducer. CIMT was measured in the outer
wall of both left and right common carotid artery (CCA), within an
area of 1 cm in length, 1 cm below the carotid bifurcation, during 3
complete cardiac cycles. All carotid images acquired at the six
participating centers were sent to a centralized reading center in
S~ao Paulo. Criteria for a valid CIMT image were: (1) clear visuali-
zation of both left and right CCA and their anatomic references; (2)
identiﬁcation of the interfaces between the lumen and the vessel
far wall; and (3) identiﬁcation of the interfaces between the media
and the adventitia layers of the far vessel wall. Only participants
with high quality image for both common carotid arteries were
included (n ¼ 10,943) [26]. We used the MIA™ software to stan-
dardize the readings and interpretation of carotid images. The
complete protocol for the CIMT measurement can be found in de-
tails elsewhere [27]. The maximal measure of IMT among the six
available measurements was considered as the independent vari-
able of this study.
2.4. Statistical analysis
The independent variable was CIMT as a continuous variable.
We described the association of CIMT and sample characteristics,
using simple linear regression. To investigate the association be-
tween CIMT and cognitive tests, we ﬁrst ﬁtted simple regression
models that included only CIMT and each of the cognitive function
tests as the dependent variables. We then adjusted these associa-
tions by including in the models the following possible confound-
ing variables: age, sex, race (White, Brown, Black, and other races),
marital status (married vs. non-married), education (high school or
less vs. college), monthly income categorized in tertiles, CVRFs
[hypertension (medical diagnosis, use of antihypertensive, systolic
blood pressure 140 mmHg or diastolic blood pressure
90 mmHg), diabetes (medical diagnosis, use of oral hypo-
glycemiant or insulin, fasting plasma glucose126mg/dl, 2-h post-
prandial 75-g glucose test 200 mg/dl, or glycosylated hemoglobin
6.5%), coronary artery disease (previous self-reported myocardial
infarction or myocardial revascularization), previous self-reported
heart failure, alcohol use (never, former, current user), smoking
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(mild, moderate, vigorous), and body mass index, depression
[evaluated using the Clinical Interview Schedule Revised (CIS-R)]
[28], and thyroid function [TSH in the reference range 0.4e4.0 IU/l;
(free T4 levels between 0.8 and 1.9mcg/dL), hypothyroidism (<0.8
mcg/dL), and hyperthyroidism (>1.9 mcg/dL)]. We also presented
the zero-order correlation coefﬁcient matrices for each pair of
variables and examined the association between CIMT and cogni-
tive function using partial correlation analyses, controlling for the
comprehensive set of confounders to test the robustness of our
results. We investigated the degree of collinearity in the linear
regression models using the variance inﬂation factor (VIF). VIF
greater than 10 was considered a sign of multicollinearity [29]. The
effect sizes of CIMT and each of the possible confounding variables
on cognitive tests were described using semi-part correlation co-
efﬁcient (SR [2]). The SR2 describes the proportion of variance in the
cognitive test that could be uniquely explained by each variable in
the model.
Finally, we tested the presence of interaction between CIMT and
selected CVRF (diabetes, coronary artery disease, heart failure,
alcohol use, and smoking) based on the hypothesis that the pres-
ence of these risk factors could modify the association between
CIMT and cognitive function. For the interaction analyses, CIMT
were categorized in quartiles, and smoking and alcohol use were
categorized as binary variables (never and former use vs. current
use) to facilitate the interpretation of the results. The presence of
interactions was tested using two-factor ANOVA, including inter-
action terms in the adjusted model for the extensive set of possible
confounders (age, sex, race, marital status, education, income, hy-
pertension, diabetes, coronary artery disease, heart failure, smok-
ing, alcohol use, physical activity, BMI, depression, and thyroid
function status). Model goodness of ﬁt was evaluated using the F-
test, the R-squared (R2), and the adjusted R2. In order to reduce the
family wise error rate due to the number of variables included in
the multivariate model, we used the Holm-Bonferroni correction to
adjust the p-values for the main associations and interactions. The
alpha level was set at 0.05 in two sided-tests. Analyses were per-
formed using SAS 9.3 (Cary, NC, USA).3. Results
Among 15,105 ELSA participants, 8208 fulﬁlled the criteria for
this study (Fig. 1). The mean age of the sample was 49.6 ± 7.3 years
(range ¼ 35e64), 44% were male, 56% White, 54% had college ed-
ucation or more. The mean CIMT was 0.73 ± 0.16 mm. Participants
recalled on average 7.1 ± 1.9 words in the DWRT and 19.0 ± 5.2Fig. 1. Flowchart of participants. CIMT ¼ carotid artery intima-media thickness.words in CFT. On average, participants spent 117 ± 79 s to complete
the TMT. A comparison of participants’ sociodemographics and
clinical variables according to CIMT is shown in Table 1. We also
presented the correlation zero-order correlation coefﬁcients be-
tween pair of variables in Supplementary Table I.
Participants had worse cognitive performance in unadjusted
analyses. However, only the association between CIMT and DWRT
remained signiﬁcant after adjustment for sociodemographics, car-
diovascular risk factors, depression, and thyroid function. (Table 2)
Increase in CIMT was associated with worse performance on DWRT
(b ¼ 0.443, 95% CI ¼ 0.724; 0.142, p ¼ 0.004). Similar results
were found when we used the partial correlation analysis.
(Supplementary Table II). After applying the Holm-Bonferroni
correction, the p-value for the association between CIMT and
DWRT performance was 0.036. CIMT was responsible for 2.6% of
DWRT variation and there was no evidence of multicollinearity in
the three multiple linear regressions models. (Supplementary
Table III).
Signiﬁcant effect modiﬁcation on TMT was found between CIMT
and heart failure (p ¼ 0.007), and between CIMT and alcohol use
(p < 0.0001). We observed worse performance in these tests,
mainly in the 4th quartile compared to the ﬁrst one (Table 3). After
adjusting the p-values for multiple comparisons, the interaction
with alcohol remained signiﬁcant (p < 0.0001) and the interaction
with heart failure had borderline signiﬁcance (p ¼ 0.07). No sig-
niﬁcant effect modiﬁcation was observed between CIMT and heart
failure or alcohol use for the other cognitive tests. In addition, we
did not ﬁnd effect modiﬁcation between CIMTand other risk factors
(diabetes, coronary artery disease, and smoking) for any of the
cognitive tests. Regarding the goodness of ﬁt of the models, the F-
tests were signiﬁcant for all models, indicating that the models
with CIMT and the confounding variables were better than the one
without any variables. However, the R2 and adjusted R2 were low,
showing that the variation of the cognitive tests explained by CIMT
and the confounding variables was small. (Supplementary Table II).
4. Discussion
In a large sample of middle-aged adults with no history of
stroke, we found an association between baseline CIMT and worse
performance on memory tests, after adjustment for an extensive
set of possible confounding variables. The relationships of CIMT
with executive function were modiﬁed by the presence of current
alcohol use. Participants with this factor and larger CIMT had worse
performance on the executive function test. The interaction be-
tween of self-reported heart failure and CIMT had borderline sig-
niﬁcance on the performance of the same test.
The predictive value of CIMT for cognitive impairment and
decline is unclear since the ﬁrst descriptions of this association.
Differences in study designs and populations may be responsible
for these discrepancies. CIMT was associated with dementia in the
Rotterdam Study [8], but higher CIMT values were only marginally
associated with cognitive impairment in men in the EVA Study
Group [30]. In cross-sectional studies of elderly participants, higher
CIMT was associated with dementia and cognitive impairment in
some studies [9,14,31], while no association was found in partici-
pants with high cardiovascular risk proﬁle [12]. In longitudinal
studies, higher CIMT predicted dementia and AD risk [6,32,33], and
cognitive decline in the elderly [10,34,35]. When middle-aged
participants were evaluated (mean age<60 years-old at baseline),
CIMT did not predict cognitive decline in the ARIC nor in the
Tromsø Study [11,13,36], while it was associated with worse per-
formance on memory and executive function tests in the Baltimore
Longitudinal Study of Aging and the Beaver Dam Offspring study
[9,15]. Since dementia has a long preclinical phase, the utility of
Table 1
Characteristics of the sample and association between covariates and carotid artery intima-media thickness (CIMT) (n ¼ 8208).
Variable Mean (SD) or % b (95% conﬁdence interval) pa
Age (years) 49.6 (7.3) 0.009 (0.008; 0.009) <0.0001
Male 44.1 0.048 (0.041; 0.054) <0.0001
Race <0.0001
White 56.3 0 (reference)
Black 14.3 0.048 (0.038; 0.058)
Brown 25.9 0.012 (0.004; 0.020)
Other 3.5 0.017 (0.001; 0.036)
Education <0.0001
High school or less 45.7 0 (reference)
College or more 54.3 0.034 (0.040; 0.027)
Marital status 0.81
Non-married 32.8 0 (reference)
Married 67.2 0.001 (0.004; 0.003)
Monthly Income (US$) tertiles 0.0007
1st: <968 36.7 0 (reference)
2nd: 968-1971 35.6 0.015 (0.023; 0.007)
3rd: >1971 27.7 0.010 (0.019; 0.002)
Hypertension 28.8 0.112 (0.105; 0.119) <0.0001
Diabetes 15.7 0.094 (0.085; 0.103) <0.0001
Dyslipidemia 57.4 0.061 (0.054; 0.068) <0.0001
Coronary artery disease 1.1 0.119 (0.087; 0.152) <0.0001
Heart failure 1.0 0.127 (0.093; 0.160) <0.0001
Alcohol use 0.0006
Never 10.0 0 (reference)
Former 18.5 0.016 (0.002; 0.029)
Current 71.5 0.002 (0.013; 0.010)
Smoking <0.0001
Never 57.8 0 (reference)
Former 28.7 0.049 (0.042; 0.057)
Current 13.5 0.045 (0.035; 0.055)
Physically active 23.2 0.009 (0.017; 0.001)
Body mass index (kg/m2) 26.6 (4.5) 0.001 (0.009; 0.011) <0.0001
Depression 4.0 0.001 (0.018; 0.0163 0.90
Thyroid function status 0.002
Normal 87.0 0 (reference)
Clinical or subclinical hypothyroidism 11.6 0.018 (0.007; 0.028)
Clinical or subclinical hyperthyroidism 1.4 0.020 (0.009; 0.049)
C-reactive protein (mg/L) 2.1 (2.1) 0.011 (0.009; 0.012) <0.0001
a Linear regression model.
Table 2
Coefﬁcients and 95% conﬁdence interval (CI) for cognitive tests, according to carotid artery intima-media thickness (CIMT) (n ¼ 8208).
Simple regression model p Multiple regression modela p
Delayed word recall test 1.978 (2.242; 1.714) <0.0001 0.433 (0.724; 0.142) 0.004
Category ﬂuency test 3.296 (4.011; 2.580) <0.0001 0.219 (0.555; 0.992) 0.56
Trail making test 81.23 (70.36; 92.10) <0.0001 3.41 (7.88; 14.71) 0.55
a Linear regression model, adjusted for age, sex, race, marital status, education, income, hypertension, diabetes, coronary artery disease, heart failure, smoking, alcohol use,
physical activity, body mass index, depression, and thyroid function status.
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mentia should be evaluated in young populations with no history of
stroke. However, most of the studies that showed association of
CIMT and cognitive impairment included mostly older participants
at baseline than our study. Zhong et al. found that larger CIMT was
associated with worse cognitive function in the Beaver Dam
Offspring study. Although the participants of this study had a mean
age similar to our sample (mean age¼ 49), it included awide range
of age groups (range ¼ 21e84) [15]. Therefore, we showed for the
ﬁrst time that CIMT was related to worse memory function in a
sample with only adults <65 years-old. The importance of this
ﬁnding is that the presence of subclinical atherosclerosis may be a
marker of ongoing cognitive impairment in this population.
Subclinical atherosclerosis in the carotid arteries was related to
cerebrovascular disease [37]. Larger CIMT was associated with
lower parietal gray matter thickness [38], lower brain volume,
more brain infarcts and white matter hyperintensities [39].Therefore, the worse performance on tests of memory and execu-
tive functions in participants with larger CIMT in our sample may
be explained by incipient cerebrovascular disease and related
changes in brain structure. To further determine the predictive
value of CIMT for cognitive impairment we tested for interaction
between CIMT and selected CVRFs. We found that participants that
used alcohol and had larger CIMT had worse performance on ex-
ecutive function. In the Northern Manhattan Study, moderate
alcohol consumption inwomenwas related to better cognition, but
this associationwas not mediated by the presence of carotid plaque
and the role of CIMT was not examined [41]. The interaction be-
tween heart failure and CIMTon TMT performance had a borderline
signiﬁcance after adjustment for multiple comparison. In one study
of outpatients with cardiovascular disease, including heart failure,
CIMT was previously associated with impairment in executive
function, but not in memory, language, and visual-spatial abilities
[40]. The presence of heart failure and related cerebral
Table 3
Estimates and effect sizewith 95% conﬁdence interval (95% CI) for the Trail Making Test, considering the interaction of quartiles of carotid artery intimamedia-thickness (CIMT)
with heart failure and alcohol use. (n ¼ 8208).
Trail making test Adjusted coefﬁcients (95% CI)a Uncorrected p-value Corrected p-valueb
Heart failure 20.28 (71.24; 30.68) 0.41 1.00
CIMT 0.03 0.20
2nd quartile 1.98 (6.28; 2.33)
3rd quartile 5.60 (10.10; 1.10)
4th quartile 0.17 (5.16; 4.82)
Interaction term (Heart failure*CIMT) 0.006 0.07
Heart failure*2nd quartile 2.80 (59.60; 65.19)
Heart failure*3rd quartile 42.39 (17.28; 102.0)
Heart failure*4th quartile 66.32 (11.27; 121.38)
Alcohol use 3.52 (4.17; 11.21) 0.08 0.33
CIMT <0.0001 <0.0001
2nd quartile 1.25 (5.99; 3.48)
3rd quartile 6.00 (10.89; 1.11)
4th quartile 3.71 (9.09; 1.66)
Interaction term (Alcohol use*CIMT) <0.0001 <0.0001
Alcohol use*2nd quartile 4.28 (15.24; 6.68)
Alcohol use*3rd quartile 5.28 (5.61; 16.17)
Alcohol use*4th quartile 22.60 (11.90; 33.30)
a Adjusted for age, sex, race, education, income, hypertension, diabetes, coronary artery disease, heart failure (for alcohol use), smoking, alcohol use (for heart failure),
physical activity, body mass index, depression, and thyroid function status.
b Corrected for multiple comparison by the Holm-Bonferroni correction.
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cerebrovascular disease and worse cognitive performance.
Our study has many strengths, including the large sample size of
middle-aged adults without a history of stroke that allowed for
adjustment for an extensive set of possible confounding variables
and investigation of interactions. In addition, we investigated for
the ﬁrst time the association between CIMT and cognitive function
in a sample outside the US, Europe, or China. Information from
developing countries is important since the prevalence and control
of CVRFs and diseases [42,43]. as well as the prevalence of cognitive
impairment [1], may vary in countries with different levels of so-
cioeconomic development. Moreover, CMIT measures were stan-
dardized among the six centers, following a systematic protocol.
However, our study should also be interpreted with some limita-
tions in mind. First, we presented information about baseline as-
sociations, because longitudinal information was not available at
this time. Additionally, we excluded participants with history of
stroke, but we could not exclude the presence of silent cerebro-
vascular disease, since neuroimaging was not available. In addition,
the ELSA-Brasil protocol evaluated IMT imaging only in common
carotid arteries, to achieve higher reproducibility among centers.
Because of this strategy, we do not have measures of internal CIMT
for these participants, and it is not possible to exclude that these
associations might be stronger if measures of internal CIMT were
available. In the Framingham Offspring Cohort, while common
CIMT was not associated with worse cognitive function, internal
CIMT was associated with verbal and non-verbal memory impair-
ment, as well as brain atrophy and cerebrovascular disease [39]. In
addition, our models showed low measures of goodness of ﬁt;
however, this fact does not invalidate our ﬁndings about the as-
sociation between CIMT and DWRT. Additionally, CIMT was
responsible for 2.6% of DWRT variance in themainmodel. Although
this is a small contribution, which may be signiﬁcant only due to
the large sample size, it was signiﬁcant even after adjustment for a
large set of well-known factors associated with cognitive perfor-
mance. In fact, only 15.5% of variance of the DWRT could be
explained by CIMT and the other possible confounding variables.
Although previous studies have found an association between CIMT
and memory and executive function, none have reported the pro-
portion of the variance of cognitive function that could be
explained by CIMT. However, the fact that only a small proportionof the DWRT variance was explained by CIMT and other variables
must be interpreted in context. For example, in a study to deter-
mine whether brain lesions predict neuropsychological deﬁcits in
patients after a stroke, demographics and neuroimaging (e.g.
cortical atrophy, total infarct volume, and white matter hyper-
intensities) explained only a small percentage of the memory test
variance (e.g. FOME delayed recall and WMS-R, logical memory).
The presence of cortical atrophy on MRI, one of the most important
structural alterations associated with dementia, only explained
14.1% and 11.3% of the variance of the FOME and WMS-R logical
memory respectively [44]. In addition, it was beyond the scope of
this study to develop and validate a prediction tool for cognitive
performance. Moreover, although we adjust our models for a
comprehensive set of confounding variables, residual confounding
may be present since we did not use any matching procedures for
these variables. Finally, we performed several statistical tests and
the possibility of type 1 error cannot be excluded.
5. Conclusions
In conclusion, CIMT was associated with worse performance on
memory tests in a large sample of middle-age adults without his-
tory of stroke. Interaction models indicated that participants with
heart failure and current use of alcohol had more intense associa-
tion between higher CIMT and worse performance on executive
function tests. CIMT may be a good marker for cognitive impair-
ment, particular in middle-age adults with these risk factors.
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